 xml:space="preserve" bytes="3270"><!-- Please do not remove or change this AfD message until the discussion has been closed. -->
{{Article for deletion/dated|page=Glenmark Pharmaceuticals|timestamp=20170513190205|year=2017|month=May|day=13|substed=yes|help=off}}
<!-- Once discussion is closed, please place on talk page: {{Old AfD multi|page=Glenmark Pharmaceuticals|date=13 May 2017|result='''keep'''}} -->
<!-- End of AfD message, feel free to edit beyond this point -->
{{Use dmy dates|date=May 2014}}
{{Use Indian English|date=June 2016}}

{{infobox company
| name             = Glenmark Pharmaceuticals
| logo             = [[File:GlenmarkLogo.jpg|200px]]
| caption          = 
| type             = Public company
|traded_as={{BSE|532296}}<br/>{{NSE|GLENMARK}})
| genre            = 
| fate             = 
| predecessor      = 
| successor        = 
| foundation       = 1977
| founders         = [[Gracias Saldanha]] 
| defunct          = 
| location_city    = [[Mumbai]], [[Maharashtra]]<ref>http://www.glenmarkpharma.com/UITemplate/HtmlContainer.aspx?res=P_GLN_CONTACT</ref>
| location_country =  [[INDIA]]
| locations        = 
| area_served      = Global
| key_people       = Glenn Saldanha, [[managing director|MD]] & Chairman<ref>{{cite web|url=http://www.glenmarkpharma.com/sites/default/files/Profile%20Glenn%20Saldanha.pdf}}</ref>
| industry         = [[Pharmaceuticals]]
| products         = Medicines and [[Vaccines]]
| services         = 
| revenue          = USD 1.2 billion <ref>http://www.bseindia.com/stock-share-price/glenmark-pharmaceuticals-ltd/glenmark/532296/</ref>
| operating_income = 
| net_income       =  
| aum              = 
| assets           = 
| equity           = 
| owner            = 
| num_employees    = Over 12,000 <ref>{{cite web|url=http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=2529483 |title=Glenmark Pharmaceuticals Ltd. (2529483): Stock Quote & Company Profile â€“ BusinessWeek |publisher=Investing.businessweek.com |accessdate=30 September 2010}}</ref>
| parent           =  
| divisions        = 
| homepage         = [http://www.glenmarkpharma.com/ www.glenmarkpharma.com]
| footnotes        = 
| intl             = yes
}}

'''Glenmark Pharmaceuticals''' is a pharmaceutical company headquartered in [[Mumbai]], [[India]].<ref>{{cite web|url=http://www.ibef.org/download/glenmark_pharma_23oct.pdf |title=about Glenmark Pharmaceuticals |publisher=ibef.org |accessdate=30 September 2010}}</ref> It is a research driven global pharmaceutical organization focused on discovering novel molecules and developing high-quality generics and specialty products for markets across the globe.<ref>http://www.glenmarkpharma.com/about-us/overview</ref>

Glenmark has 17 manufacturing facilities across 5 countries including US, Argentina, Czech Republic and India.<ref>http://www.glenmarkpharma.com/formulations/formulations-manufacturing-facilities</ref> Glenmark has 5 R&D centers around the world engaged in discovery of novel biological and chemical entities.

==References==
{{reflist}}

[[Category:Companies based in Mumbai]]
[[Category:Pharmaceutical companies of India]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Pharmaceutical companies established in 1977]]


{{India-company-stub}}